Table 1.
Distribution of demographic, clinical and pathologic CRC variables
| Number | Results | |
|---|---|---|
| Age, median (Interquartile range) | 214 | 63 (53–72) |
| Male, no (%) | 216 | 106 (49) |
| Location | 210 | |
| Ascending | 86 (41 %) | |
| Transverse | 21 (10 %) | |
| Descending | 26 (12 %) | |
| Rectosigmoid | 77 (37 %) | |
| Histology | 215 | |
| Adenocarcinoma | 179 (83 %) | |
| Mucinous Adenocarcinoma | 31 (14 %) | |
| Other | 5 (3 %) | |
| Chemotherapy before surgery, no (%) | 216 | 11 (5 %) |
| Radiotherapy before surgery, no (%) | 216 | 11 (5 %) |
| Grade | 193 | |
| Low | 184 (95 %) | |
| High | 10 (5 %) | |
| Stage, no (%) | 209 | |
| I | 46 (22 %) | |
| II | 71 (34 %) | |
| III | 74 (35 %) | |
| IV | 18 (9 %) | |
| Number of LN resected | 214 | |
| ≤12 | 77 (36 %) | |
| >12 | 137 (64 %) | |
| Median (interquartile) | 15 (10–22) | |
| Tumor size, Median (interquartile) cm | 192 | 4.5 (3.0-5.7) |
| Specimen size, Median (interquartile) cm | 188 | 33 (21–61) |
| Number of metastatic LNs, Median (interquartile) | 214 | 0 (0–2) |
| Ratio of metastatic LNs to total LNs examined, Median (interquartile) | 214 | 0 (0–0.09) |
| *Some of the data is missing |
n = 216*